about
Dendrimer ProdrugsDrug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and ChallengesDrug delivery systems, CNS protection, and the blood brain barrierProdrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380New tools for the quantitative assessment of prodrug delivery and neurotoxicity.Small endogenous molecules as moiety to improve targeting of CNS drugs.Research and development in drug innovation: reflections from the 2013 bioeconomy conference in China, lessons learned and future perspectivesExploring hydrogen peroxide responsive thiazolidinone-based prodrugs.Integration concepts for multi-organ chips: how to maintain flexibility?!Virus-directed enzyme prodrug therapy and the assessment of the cytotoxic impact of some benzimidazole derivatives.Recent updates in utilizing prodrugs in drug delivery (2013-2015).Potential of novel drug delivery strategies for the treatment of hyperlipidemia.Advances in oral delivery of anti-cancer prodrugs.Computational approaches for innovative antiepileptic drug discovery.Vectorization of agrochemicals: amino acid carriers are more efficient than sugar carriers to translocate phenylpyrrole conjugates in the Ricinus system.Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light.Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro.Bile Acid Conjugated DNA Chimera that Conditionally Inhibits Carbonic Anhydrase-II in the Presence of MicroRNA-21.Vectorisation of agrochemicals via amino acid carriers: influence of the spacer arm structure on the phloem mobility of phenylpyrrole conjugates in the Ricinus system.Azulene-Based Macrocyclic Receptors for Recognition and Sensing of Phosphate Anions.Investigation of acid phosphatase variants for the synthesis of phosphate monoesters.Overcoming challenges associated with the bioanalysis of an ester prodrug and its active acid metabolite.Modern prodrug design for targeted oral drug delivery.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and LigandsEvaluation of Natural and Synthetic Phosphate Donors for the Improved Enzymatic Synthesis of Phosphate Monoesters
P2860
Q26743392-9409A7D0-FEB6-4FA0-A5A5-EA1126D0E837Q26798105-CF41BB79-3D56-4DF0-9835-F22B28BBBCF6Q30432845-5B0B4580-0C45-4BBB-A50F-28CC60EB7AACQ34231935-45713F66-5B38-4C25-81F0-7E113EC66159Q35849165-4426FB0C-0987-479D-B396-78BB96AB5C56Q36065879-5E5A984A-D515-474D-AEBC-B0BC8F106E3AQ36110865-435C43D8-F184-40D4-BECA-B1BAD5421389Q36319951-1CA19D14-6770-4DD9-81BD-F17BDDE37B35Q38663725-7E2BCE6F-1507-4F6B-A3FC-F5C1293D9CC9Q38696221-34BF88FA-6A2C-4C8B-B1C0-35E727E15DE8Q38702949-83D35668-48EC-4647-95BB-B6AC57675256Q38794030-EBA56420-7E08-4E8C-AB84-AA7E1CE87DE7Q38862820-5C1056D2-113A-4927-BDF8-87BBBC6F7D6CQ38907478-7C0FFFB4-BD48-4F37-8471-48D74038D9C1Q39103084-7ED3080A-6983-4E4E-9949-22D0B5F40B42Q40334818-36BA8368-A184-48CF-A9E0-935CB59BDA31Q41882677-4129667A-433B-472B-B1DF-28628A06DBF5Q42029049-CA4DF0B4-7CFF-4FFB-B617-49BF22C77A29Q42153678-8E5785BB-511C-40D7-8766-224B3C6AE3EFQ48099635-C03DD9FD-39E1-43EE-B442-CB6B47F72E9BQ48277863-422F2BD9-D610-40F2-89EF-3736D9072CC3Q48296302-EBA206E4-870E-466A-B3F1-645852358A40Q50088567-937A5A22-F63A-4B35-AF0F-65A968DDDD85Q51042522-F64FE791-9A8B-4F8B-A245-6C173C3D2244Q57693525-C609CC6B-8C20-4D30-9CB0-2E9CE282AF7CQ58572199-A0558F43-379A-4DD7-BDCD-EA2C44C6D367
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prodrugs: a challenge for the drug development.
@ast
Prodrugs: a challenge for the drug development.
@en
Prodrugs: a challenge for the drug development.
@nl
type
label
Prodrugs: a challenge for the drug development.
@ast
Prodrugs: a challenge for the drug development.
@en
Prodrugs: a challenge for the drug development.
@nl
prefLabel
Prodrugs: a challenge for the drug development.
@ast
Prodrugs: a challenge for the drug development.
@en
Prodrugs: a challenge for the drug development.
@nl
P1476
Prodrugs: a challenge for the drug development.
@en
P2093
Jolanta B Zawilska
P356
10.1016/S1734-1140(13)70959-9
P577
2013-01-01T00:00:00Z